Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis: Results from a Single Lupus Cohort

Table 2

Patient demographics at the diagnosis of LN.

Demographics
Female	87 (86.1%)
Ethnicity
Caucasian	63 (62.4%)
Black	18 (17.8%)
Asian	12 (11.9%)
Others	8 (7.9%)
Age at SLE diagnosis (years)	28.64 ± 10.89
Age at LN (years)	32.99 ± 10.66
Disease duration at LN (years)	4.36 ± 4.60
Disease scores
SLEDAI-2K at LN diagnosis	13.29 ± 7.14
SDI at LN diagnosis	0.44 ± 0.95
Treatment
Treated with glucocorticoids at LN	93 (92.1%)
Treated with antimalarials at LN	52 (51.5%)
Treated with immunosuppressives at LN	60 (59.4%)
Treated with ACE inhibitor/ARB	40 (39.6%)
Laboratory tests at LN diagnosis
24H-P (g/d) median (interquartile range)	1.5 (0.9–2.9)
24H-P (g/d) mean at baseline	2.36 ± 2.31
24H-P (g/d) mean at year 1	1.17 ± 1.59
uRBCs (hpf) median (interquartile range)	5.0 (0.0–10.0)
Cr (mmol/L) median (interquartile range)	72.0 (64.0–89.0)